G

Grand Pharmaceutical Group Ltd
HKEX:512

Watchlist Manager
Grand Pharmaceutical Group Ltd
HKEX:512
Watchlist
Price: 4.75 HKD 0.21% Market Closed
Market Cap: 16.9B HKD
Have any thoughts about
Grand Pharmaceutical Group Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Grand Pharmaceutical Group Ltd

Current Assets 8.2B
Cash & Short-Term Investments 2.3B
Receivables 4.6B
Other Current Assets 1.3B
Non-Current Assets 16.7B
Long-Term Investments 8.4B
PP&E 4B
Intangibles 3.3B
Other Non-Current Assets 892m
Current Liabilities 6.4B
Accounts Payable 3.5B
Short-Term Debt 26m
Other Current Liabilities 2.9B
Non-Current Liabilities 2.8B
Long-Term Debt 2.1B
Other Non-Current Liabilities 712.8m

Balance Sheet
Grand Pharmaceutical Group Ltd

Rotate your device to view
Balance Sheet
Currency: HKD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
460
654
484
641
912
1 059
1 837
1 753
1 444
1 340
Cash
460
654
484
641
912
1 059
1 837
1 753
1 444
1 340
Short-Term Investments
50
1
11
18
46
72
521
1 113
1 039
1 135
Total Receivables
1 005
1 082
1 310
1 348
1 362
1 555
1 716
2 149
2 207
2 324
Accounts Receivables
350
466
697
908
929
898
815
968
1 094
958
Other Receivables
656
617
613
440
433
657
901
1 182
1 113
1 366
Inventory
517
622
636
763
770
814
955
1 117
1 340
1 389
Other Current Assets
101
47
39
178
339
316
290
646
857
829
Total Current Assets
2 133
2 406
2 481
2 947
3 429
3 816
5 319
6 779
6 887
7 016
PP&E Net
2 291
2 543
2 644
2 892
2 876
3 264
3 410
3 802
3 942
3 986
PP&E Gross
2 291
2 543
2 644
2 892
2 876
3 264
3 410
3 802
3 942
3 986
Accumulated Depreciation
241
401
542
794
932
1 366
1 641
1 910
2 057
2 264
Intangible Assets
68
651
796
876
816
795
882
1 010
1 398
1 657
Goodwill
125
381
481
512
488
480
506
597
644
589
Note Receivable
0
14
0
0
0
0
114
0
0
0
Long-Term Investments
46
322
371
439
5 481
5 341
6 437
8 380
8 447
8 398
Other Long-Term Assets
305
316
368
397
407
117
317
491
1 054
870
Other Assets
125
381
481
512
488
480
506
597
644
589
Total Assets
4 991
N/A
6 633
+33%
7 142
+8%
8 063
+13%
13 497
+67%
13 813
+2%
16 984
+23%
21 057
+24%
22 371
+6%
22 515
+1%
Liabilities
Accounts Payable
655
653
702
628
1 056
834
662
734
873
1 330
Accrued Liabilities
466
529
662
942
1 287
1 192
1 477
2 137
1 615
1 499
Short-Term Debt
12
0
0
0
285
0
60
7
25
19
Current Portion of Long-Term Debt
1 089
2 006
1 712
2 222
2 021
990
1 575
2 122
3 253
2 353
Other Current Liabilities
50
61
81
215
318
573
529
565
689
530
Total Current Liabilities
2 273
3 249
3 157
4 007
4 967
3 590
4 303
5 566
6 455
5 731
Long-Term Debt
668
1 179
1 211
769
320
1 075
814
1 523
1 222
1 052
Deferred Income Tax
59
144
189
196
179
172
182
198
220
222
Minority Interest
195
245
274
226
244
136
105
50
68
113
Other Liabilities
683
657
609
632
596
467
342
327
265
240
Total Liabilities
3 877
N/A
5 474
+41%
5 440
-1%
5 829
+7%
6 306
+8%
5 438
-14%
5 745
+6%
7 664
+33%
8 231
+7%
7 358
-11%
Equity
Common Stock
20
20
22
22
31
34
35
35
35
35
Retained Earnings
677
787
1 044
1 469
2 183
3 037
4 506
6 535
8 224
9 607
Additional Paid In Capital
282
282
661
661
5 052
5 511
6 523
6 523
6 523
6 523
Unrealized Security Profit/Loss
0
0
0
0
1
1
12
3
99
279
Treasury Stock
0
0
0
0
0
0
0
144
187
269
Other Equity
135
71
24
82
76
208
163
440
355
460
Total Equity
1 113
N/A
1 160
+4%
1 702
+47%
2 234
+31%
7 191
+222%
8 375
+16%
11 240
+34%
13 393
+19%
14 140
+6%
15 158
+7%
Total Liabilities & Equity
4 991
N/A
6 633
+33%
7 142
+8%
8 063
+13%
13 497
+67%
13 813
+2%
16 984
+23%
21 057
+24%
22 371
+6%
22 515
+1%
Shares Outstanding
Common Shares Outstanding
1 973
1 973
2 249
2 249
3 135
3 378
3 550
3 550
3 519
3 502

See Also

Discover More